United States

People: Bristol-Myers Squibb Co (BMYMP.PK)

BMYMP.PK on OTC Markets Group

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Caforio, Giovanni 

Dr. Giovanni Caforio M.D., has been appointed as Chairman of the Board, Chief Executive Officer of the Company effective May 2, 2017. He was Chief Executive Officer, Director of Bristol-Myers Squibb Company effective May 5, 2015. He was Chief Executive Officer-Designate from January to May 2015, Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014. From October 2011 to November 2013, he served as President, U.S. He held the position of Senior Vice President, Global Commercialization and Immunology from May 2010 to October 2011. Prior to that, he served as Senior Vice President, Oncology, U.S. and Global Commercialization from March 2009 to May 2010. From January 2007 to March 2009 he served as Senior Vice President, U.S. Oncology and from May 2004 to January 2007, he served as Senior Vice President, European Marketing and Brand Commercialization. Dr. Caforio is a member of the Board of Trustees of Capital Health Systems and the Pharmaceutical Research and Manufacturers of America.

Basic Compensation

Total Annual Compensation, USD 4,786,690
Restricted Stock Awards, USD 10,443,900
Long-Term Incentive Plans, USD --
All Other, USD 409,844
Fiscal Year Total, USD 15,640,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lamberto Andreotti


Giovanni Caforio


Charles Bancroft


Louis Schmukler


Francis Cuss


Sandra Leung

As Of  30 Dec 2015